Animal model pk pd a tool for drug development l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 17

Animal Model PK/PD: A Tool for Drug Development PowerPoint PPT Presentation


  • 241 Views
  • Uploaded on
  • Presentation posted in: General

Animal Model PK/PD: A Tool for Drug Development. David Andes, MD University of Wisconsin Madison, WI USA. Parameters of Interest:. C max (Peak). Time > MIC . C max /MIC ratio. AUC/MIC ratio. Area under the curve:. Concentration. AUC. MIC. Time > MIC. Time (hours).

Download Presentation

Animal Model PK/PD: A Tool for Drug Development

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Animal model pk pd a tool for drug development l.jpg

Animal Model PK/PD: A Tool for Drug Development

David Andes, MD

University of Wisconsin

Madison, WI USA


Pharmacokinetics l.jpg

Parameters of Interest:

Cmax (Peak)

  • Time > MIC

  • Cmax/MIC ratio

  • AUC/MIC ratio

Area under the curve:

Concentration

AUC

MIC

Time > MIC

Time (hours)

Pharmacokinetics

Pharmacodynamics

Antimicrobial PK + MIC + Outcome


The primary animal model pharmacodynamic questions l.jpg

Predictive PD Parameter – What PK characteristic do I optimize?

Magnitude of PD Parameter – How much drug do I need?

PD Magnitude Variables – What factors impact how much drug I need?

Study PD Correlation in humans – Can this help predict outcome in clinical disease?

The Primary Animal Model Pharmacodynamic Questions


Slide4 l.jpg

Correlation of PK/PD Parameters with Efficacy

for Ceftazidime against Pseudomonas aeruginosa

in a Murine Thigh-Infection Model

Andes & Craig, Int J Antimicrob Agents, 2002


Mathematical analysis of dose response data from animal models after 24 hours of therapy l.jpg

Mathematical Analysis of Dose-Response Data from Animal Models after 24 Hours of Therapy

Nonlinear regression and Hill equation to estimate Emax (difference from untreated control), P50 (dose giving 50% of Emax) and slope (N) of the dose-response relationship

(Emax) DoseN

CFU=

DoseN + P50N


Slide6 l.jpg

PD Magnitude Variables

  • Drug class

  • Dosing regimen

  • Protein binding

  • Site of infection

  • Infecting pathogen

  • Resistance in the infecting pathogen

  • Immune system

  • Treatment endpoint


Slide7 l.jpg

Relationship Between T>MIC and Efficacy for Carbapenems (Red), Penicillins (Aqua) and Cephalosporins (Yellow)


Slide8 l.jpg

24-Hr AUC/MIC with Total and Free Drug for the Static Dose of Different Fluoroquinolones with S. pneumoniae ATCC 10813

Andes & Craig 40th and 41st ICAAC, 2000 and 2001


Pharmacodynamic goals t mic as percent of interval with beta lactams l.jpg

Maximum

ClassOrganism StasisKilling

Cephalosporins GNR, pneumo 40-50 70-80

Staph 20-30 40-50

Penicillins GNR, pneumo 30-40 60-70

Staph 20-30 40-50

Carbapenems GNR, staph 20-30 40-50

Pneumo 10-20 25-40

Pharmacodynamic Goals (T>MIC as percent of Interval) with Beta-Lactams


Slide10 l.jpg

Relationship Between MIC and T>MIC for the Static Dose for Amoxicillin and Cefpodoxime with strains of S. pneumoniae

Andes & Craig AAC 42:2375, 1998; Urban, Andes, Craig 19th ICC, 1995


Slide11 l.jpg

Relationship Between T>MIC and Efficacy for Amoxicillin against S. pneumoniae in Murine Pneumonia and Thigh-Infection Models

Craig CID 33(Suppl 3):S233, 2001


Literature review for t mic for beta lactams versus mortality in animal models l.jpg

Literature Review for T>MIC for Beta-Lactams Versus Mortality in Animal Models

Streptococcus pneumoniae

  • At least 48 hours of treatment

  • Mortality 80-100% in untreated controls

  • Pharmacokinetics provided to calculate magnitude of PK/PD parameter

  • Mortality recorded within 24 hrs after last dose of drug

  • Data from 3 animal species and 4 sites of infection


Slide13 l.jpg

3 QuinolonesK. pneumoniaeThigh

2 AminoglycosidesP. aeruginosaLung

4 B-lactamsS. pneumoniae


Slide15 l.jpg

NL

Neut

NL

Neut


Slide16 l.jpg

Comparison of the Relationships Between Efficacy and 24-Hr AUC/MIC for Fluoroquinolones in Animal Models and Infected Patients

Animals - Literature Review

Seriously ill patients + Ciprofloxacin

24-Hr AUC/MIC

Forrest et al. AAC 37:1073, 1993

Andes, Craig Int J Antimicrob Agents, 2002


Slide17 l.jpg

Correlation of PK/PD Parameters with Efficacy for Ceftazidime against Pseudomonas aeruginosa

in a Murine Thigh-Infection Model


  • Login